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Botero’s Fat Figures and
the Risk of Heart Failure*
Eileen Hsich, MD
Cleveland, Ohio
Is there such a thing as a “healthy fat” person? Can obesity
be less risky than maintaining normal weight? The answer is
yes, if the normal-weight individual has the metabolic
syndrome (MetS). With cardiovascular disease, this has
been referred to as the “obesity paradox” (1). As we further
understand the relationship between body mass index
(BMI) and cardiovascular risk, we realize that the excess
cardiovascular deaths observed in obese patients compared
with normal-weight patients (2) may be due to other factors
including a higher prevalence of MetS among obese patients
(2). In fact, the paper by Voulgari et al. (3) in this issue of
the Journal nicely demonstrates that MetS better correlates
with development of heart failure (HF) than BMI.
See page 1343
The association of obesity with HF has been known since at
least the 1950s when a 43-year-old “monstrously” obese man
died of biventricular heart failure, and the autopsy revealed a
heart weighing 600 g with dilated and hypertrophied ventricles
(right  left) (4). Since that case report, epidemiological
studies have shown a higher risk of the development of left
ventricular hypertrophy (5), left ventricular dilation (6), dia-
stolic dysfunction (7), and clinical HF (8–12) among obese
ndividuals compared with those of normal weight. In the
ramingham Heart Study involving 5,881 participants who
ere followed for a mean of 14 years, there was a 5% increased
isk of HF in men and a 7% increased risk of HF in women for
very 1-U increase in BMI after adjusting for known risk
actors, such as hypertension and diabetes mellitus (9). The risk
f HF was present whether obesity was defined by BMI
8–12), waist circumference (8,10,13), or waist–hip ratio
8,10). In studies that separated the cohort by sex (8–10,14)
nd/or race (8), this association was still present.
The obesity paradox in HF refers to the lower risk of urgent
ransplantation and/or death observed among obese HF pa-
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ecompensated HF based on ADHERE (Acute Decompen-
ated Heart Failure National Registry), which had 108,927
atients, there was a 10% lower risk-adjusted mortality (95%
onfidence interval: 0.88 to 0.93, p 0.0001) for every 5-unit
ncrease in BMI (15). In chronic HF based on the CHARM
Candesartan in Heart failure: Assessment of Reduction in
ortality and morbidity) cohort (N  7,599), obese patients
ith reduced and preserved left ventricular ejection fraction
LVEF) had a lower mortality rate than lean and overweight
atients (16). Most of the studies noting this obesity paradox
ave defined obesity by BMI (15–20) except for 1 study that
bserved the “paradox” when obesity was defined by waist
ircumference (WC) (21) and another that used percentage of
ody fat (defined by the skinfold technique) and total body fat
22). These last 2 studies have challenged the argument that
he obesity paradox is predominantly due to the limitations of
MI, which are dependent on the percentage of body fat and
an vary based on age, sex, and race (23–25). However,
dditional studies are needed to verify these results because the
tudies involved small cohorts (WC study: N  344; body fat
tudy: N  201), few clinical events (WC study: 68 events;
ody fat study: 28 events), and a limited patient population
systolic HF only).
The Voulgari et al. (3) study did not demonstrate an
ssociation between obesity defined by BMI and HF in the
ubgroup of patients without MetS. Their study differs from
he other epidemiologic studies evaluating risk factors for HF
ue to exclusion of patients with diabetes mellitus and macro-
ascular disease, separation of patients into those with and
ithout metabolic syndrome, and few cardiac events (HF
eveloped in 185 patients), limiting the power of the analysis.
he strength of their analysis was the use of the National
holesterol Education Program Adult Treatment Panel III
NCEP-ATP III) criteria for MetS, cardiac catheterization in
bout 83% of the cohorts to rule out subclinical coronary artery
isease, and few patients lost to follow-up. It was also a
rospective study with echocardiograms obtained for all pa-
ients. Although it was relatively small, the study did demon-
trate that MetS better correlated with the development of HF
han just BMI. Their findings give credence to the existence of
“metabolically healthy population” and raises concern about
hose with MetS.
The metabolic syndrome is defined by abdominal obesity,
ypertension, high triglyceride level, and low levels of high-
ensity lipoprotein cholesterol, and insulin resistance. Different
efinitions have been proposed by many organizations over the
ears, and the one currently adopted is the NCEP-ATP III
riteria (2,26), which was used in the Voulgari et al. (3)
tudy. The metabolic syndrome, such as obesity, is consid-
red a risk factor for the development of left ventricular
ypertrophy (27), left ventricular dilation (27), myocardial
ysfunction (27,28), and clinical HF (29–32). In the Third
ational Health and Nutrition Examination Survey, people
ith MetS had almost twice the risk of the development of
11
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components of MetS are known risk factors for HF (2), it is
not surprising that MetS is a stronger predictor of HF than
simply 1 variable such as the presence of obesity.
How should we incorporate this information into our daily
medical practices, especially given data showing that MetS is a
better predictor of cardiovascular outcome than obesity defined
by BMI (33)? We currently record patients’ weight and vital
signs and assess for cardiovascular risk factors such as diabetes
mellitus and hyperlipidemia when they come to our office. Do
we really need a scale or simply a measuring tape? How should
we advise obese patients without MetS given the lower
incidence of HF in the Voulgari et al. (3) study and a lower risk
of cardiovascular events in the ULSAM (Uppsala Longitudinal
Study of Adult Men) (33)? Do we tell them that they are
among the “metabolically healthy obese” population and sug-
gest that eating cheeseburgers and French fries is okay as long
as they do not meet NCEP-ATP III criteria for MetS? The
answer lies in Fernando Botero’s paintings. He is a neo-
figurative Columbian artist who paints healthy-appearing
young and middle-age obese people dancing, wrestling, and
enjoying life. What is missing in his paintings and in our clinics
is healthy elderly obese women and men. At an older age, they
probably are no longer healthy.
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